First human tests begin for potential ulcerative colitis drug
NCT ID NCT07350577
Summary
This early-stage study aims to check the safety and basic behavior of an experimental drug called ALTB-268 in healthy volunteers. Researchers will give single, increasing doses to 24 healthy adults to monitor for side effects and see how the drug moves through the body. The results will help determine if ALTB-268 is safe enough to test in people with ulcerative colitis in future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Syneos Health Clinical Research Services, LLC
RECRUITINGMiami, Florida, 33136, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.